Telzir



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hiv Infection 85.8%
Drug Use For Unknown Indication 3.8%
Atrial Fibrillation 1.2%
Prophylaxis 1.2%
Systemic Antiviral Treatment 1.2%
Depression 1.0%
Product Used For Unknown Indication 0.9%
Cerebral Toxoplasmosis 0.6%
Hiv Infection Cdc Category B3 0.6%
Hiv Infection Cdc Category C3 0.6%
Epilepsy 0.4%
Infection Prophylaxis 0.4%
Affective Disorder 0.3%
Bronchopulmonary Disease 0.3%
Hepatitis C 0.3%
Hiv Infection Cdc Category B2 0.3%
Hypertension 0.3%
Hypothyroidism 0.3%
Pulmonary Arterial Hypertension 0.3%
Vaginal Infection 0.3%
Hepatotoxicity 14.8%
Death 8.0%
Transaminases Increased 8.0%
Myositis 6.8%
Rhabdomyolysis 5.7%
Vomiting 5.7%
Drug Rash With Eosinophilia And Systemic Symptoms 4.5%
Premature Baby 4.5%
Skin Disorder 4.5%
Umbilical Hernia 4.5%
Hepatic Enzyme Increased 3.4%
Pancreatitis Acute 3.4%
Rash 3.4%
Rash Generalised 3.4%
Septic Shock 3.4%
Skin Exfoliation 3.4%
Tachyphrenia 3.4%
Urticaria 3.4%
Weight Decreased 3.4%
Anaemia 2.3%
Secondary
Hiv Infection 64.8%
Depression 5.0%
Product Used For Unknown Indication 4.8%
Drug Use For Unknown Indication 4.7%
Atrial Fibrillation 3.6%
Prophylaxis Against Hiv Infection 2.2%
Hiv Test Positive 1.9%
Trigeminal Neuralgia 1.7%
Pulmonary Hypertension 1.5%
Type 2 Diabetes Mellitus 1.5%
Hyperlipidaemia 1.3%
Contusion 1.2%
Anxiety 1.0%
Systemic Antiviral Treatment 1.0%
Drug Exposure During Pregnancy 0.8%
Acquired Immunodeficiency Syndrome 0.7%
Arthralgia 0.6%
Contraception 0.6%
Hiv Infection Cdc Category C3 0.6%
Cerebral Toxoplasmosis 0.5%
Hepatotoxicity 8.4%
Myocardial Infarction 8.4%
Myositis 7.2%
Thrombocytopenia 7.2%
Urticaria 7.2%
Vomiting 7.2%
Cytolytic Hepatitis 6.0%
Skin Ulcer 6.0%
Ventricular Arrhythmia 6.0%
Drug Rash With Eosinophilia And Systemic Symptoms 4.8%
Death 3.6%
Drug Exposure During Pregnancy 3.6%
Drug Resistance 3.6%
Impaired Work Ability 3.6%
Neutropenia 3.6%
Weight Decreased 3.6%
Coagulation Factor Deficiency 2.4%
Cystitis Haemorrhagic 2.4%
Gastrointestinal Disorder 2.4%
Hypoaesthesia 2.4%
Concomitant
Hiv Infection 70.5%
Drug Use For Unknown Indication 6.1%
Infection 3.0%
Hepatitis B 2.7%
Hepatitis C 2.3%
Product Used For Unknown Indication 2.1%
Acquired Immunodeficiency Syndrome 1.7%
Mixed Hyperlipidaemia 1.5%
Antiretroviral Therapy 1.3%
Drug Exposure During Pregnancy 1.1%
Prophylaxis 1.1%
Antifungal Prophylaxis 0.9%
Cerebral Toxoplasmosis 0.8%
Ear Pain 0.8%
Headache 0.8%
Herpes Virus Infection 0.8%
Hiv Test Positive 0.8%
Induction Of Anaesthesia 0.8%
Anaemia Of Chronic Disease 0.6%
Arthralgia 0.6%
Osteonecrosis 6.9%
Pancreatitis 6.9%
Pyrexia 6.9%
Varices Oesophageal 6.9%
Weight Decreased 6.9%
Autoimmune Thyroiditis 5.2%
Emphysema 5.2%
Polyarteritis Nodosa 5.2%
Rash Erythematous 5.2%
Rash Generalised 5.2%
Renal Colic 5.2%
Renal Failure Acute 5.2%
Weight Increased 5.2%
Death 3.4%
Disturbance In Attention 3.4%
Glomerular Filtration Rate Decreased 3.4%
Jaundice Cholestatic 3.4%
Metastatic Neoplasm 3.4%
Myalgia 3.4%
Myocardial Infarction 3.4%
Interacting
Hiv Infection 91.7%
Hodgkin's Disease 8.3%
Mental Disorder Due To A General Medical Condition 33.3%
Osteonecrosis 33.3%
Underdose 33.3%